This volume investigates the correlation between the biochemical mechanisms of monoamine oxidase inhibitors and their observed clinical outcomes in psychiatric and neurological treatment. Edited by J. Cheymol and J. R. Boissier, this collection compiles research presented at the Third International Pharmacological Meeting. It provides a technical framework for understanding how enzyme inhibition influences neurotransmitter levels and subsequent patient responses within the medical landscape of the mid-1960s.

Researchers and medical historians view this volume as a foundational record of mid-century psychopharmacological inquiry. The text is highly technical and intended for specialists seeking to understand the historical development of monoamine oxidase inhibitor research.